Jscreen Promoted Reproductive Genetic Testing

The organization highlighted carrier screening options throughout Tay-Sachs Awareness Month this September.

Updated on Sept. 23, 2026 in Judaism

Bold vector editorial illustration of a generic saliva collection kit resting on a surface, signifying reproductive genetic health screening. — Jscreen promoted its genetic carrier screening program throughout September to increase awareness of hereditary risks for over 260 genetic diseases. AI Illustration. Upload story photo >

Live Poll

Do you believe reproductive genetic carrier screening should be a standard part of family planning?

During Tay-Sachs Awareness Month in September 2026, Jscreen promoted its reproductive carrier screening program. The initiative aims to help individuals identify risks for more than 260 genetic diseases.

Why it matters

Tay-Sachs is an inherited neurological disease caused by the absence of the HexA enzyme, which can pass silently through generations because carriers generally exhibit no symptoms. If both parents carry a disease-causing variant, each pregnancy faces a 25% chance of being affected.

Jscreen provides a testing panel covering over 260 genetic diseases. Couples identified as high-risk can utilize the program to discuss family-building options with genetic counselors.

The players

Jscreen

This is a national public health initiative that provides at-home genetic testing and counseling services.

Havi Goldstein

A child who passed away from Tay-Sachs disease in 2021.

Evan Ungerleider

A child who was diagnosed with Tay-Sachs disease at 13 months old and died at age 4½.

The details

The Jscreen process requires individuals to order a test online, provide a saliva sample, and complete a telehealth genetic counseling session. The program highlights the stories of individuals like Havi Goldstein and Evan Ungerleider, who both died from the condition, to raise awareness of hereditary risks.

Evan Ungerleider was born in August 1994.
Havi Goldstein died in 2021.
September 2026 served as the designated Tay-Sachs Awareness Month.

Allergies
Sept. 18
FDA Approved Fayuvi for Sanfilippo Syndrome Type A
Judaism
Sept. 24
Jewish Lawmakers Opposed State Department Office Merger
Cancer
Sept. 22
Cleveland Clinic Evaluates AI for Prostate Cancer

Culture Shift

This effort is part of a broader societal move toward increased utilization of preventative genomic screening. It reflects a growing reliance on telehealth and remote diagnostic tools to manage hereditary health risks.

The screening process allows individuals to understand their carrier status from home, which may influence long-term family-building decisions. Participants receive professional guidance on genetic risks that are otherwise undetectable without specific testing.

The takeaway

Genetic carrier screening serves as a vital tool for families to understand their risk profile for inherited conditions. Proactive testing and genetic counseling can provide critical information for those planning for pregnancy.